MEDIORG — Medicamen Organics Balance Sheet
0.000.00%
- IN₹351.59m
- IN₹460.17m
- IN₹252.72m
Annual balance sheet for Medicamen Organics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | ARS | ARS | ARS | PROSPECTUS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Cash and Short Term Investments | 9.01 | 4.45 | 5.59 | 5.53 |
Net Total Accounts Receivable | ||||
Net Total Receivables | 111 | 103 | 139 | 206 |
Total Inventory | ||||
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 149 | 156 | 206 | 273 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 105 | 103 | 98.1 | 105 |
Net Intangible Assets | ||||
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 255 | 261 | 307 | 386 |
Accounts Payable | ||||
Notes Payable / Short Term Debt | ||||
Current Portion of Long Term Debt / Capital Leases | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 165 | 171 | 209 | 218 |
Long Term Debt | ||||
Capital Lease Obligations | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Deferred Income Tax | ||||
Total Other Liabilities | ||||
Total Liabilities | 182 | 187 | 220 | 234 |
Common Stock | ||||
Retained Earnings (Accumulated Deficit) | ||||
Total Equity | 73.6 | 74.7 | 86.9 | 152 |
Total Liabilities & Shareholders' Equity | 255 | 261 | 307 | 386 |
Total Common Shares Outstanding |